CELEBRATION, Fla. – A surgical team at AdventHealth recently became the first in the state to use a groundbreaking new surgical robot.
Dr. Vipul Patel, a world leader in robot-assisted prostatectomy procedures, performed the first procedure in early April using the da Vinci 5 system, and will continue to utilize the new surgical robot.
The da Vinci 5 succeeds the da Vinci Xi, which has been in wide use at AdventHealth and health systems around the world since its debut in 2014. It has been used in more than 7 million procedures to date, according to manufacturer Intuitive.
“This new technology is the next step in the future of robotic surgery,” Patel said. “The da Vinci 5 promises new innovation to facilitate improved surgeon comfort and data feedback.”
Among the new features:
- More ergonomic design for surgeon comfort
- Next-generation 3D display
- 10,000 times the computing power of the previous model
- Connectivity with other technology in the OR that may streamline procedures and save time for surgical teams.
Robotic surgery is minimally invasive, and has a track record indicating improved outcomes and better patient experience in certain procedures compared to traditional open surgeries or minimally invasive laparoscopic procedures.
“At AdventHealth, we pride ourselves on being leaders in health care innovation,” said Amanda Maggard, CEO of AdventHealth Celebration. “Bringing this technology right here to Celebration allows us to provide leading-edge treatment that’s convenient and close to home.”
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
News
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
